P1-347Actual clinical use of Ramucirumab plus Paclitaxel at our hospital
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Oncology"
DOI: 10.1093/annonc/mdx621.038
Abstract: Results: The median follow-up was 13.7 months (range: 3.1-25.2 months). The median age was 70 years (range: 56-82 years), and 5 patients were male. The primary sites of mucosal malignant melanoma were head and neck… read more here.
Keywords: plus paclitaxel; clinical use; 347actual clinical; use ramucirumab ... See more keywords